Get startedLog in
    Picture of Kobayashi Pharmaceutical Co logo

    4967 — Kobayashi Pharmaceutical Co Cashflow Statement

    0.000.00%
    jp flag iconLast trade - 00:00
    Consumer DefensivesBalancedMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Kobayashi Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:YuhoYuhoYuhoYuhoYuho
    Standards:
    JAS
    JAS
    JAS
    JAS
    JAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line26,63527,63627,95027,55913,914
    Depreciation
    Amortisation
    Non-Cash Items199-276-351-1,0522,598
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-6,956-9,776-1,065-14,204-13,288
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Taxes Payable
    Other Operating Cash Flow
    Cash from Operating Activities23,98422,41931,89218,36011,246
    Capital Expenditures-4,149-4,185-16,229-13,569-26,629
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-8,50712,1761,917-6,0078,214
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-12,6567,991-14,312-19,576-18,415
    Financing Cash Flow Items-230-171-193-240-263
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-6,019-10,377-20,759-19,463-7,768
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash4,88420,830-2,506-19,789-13,717